Prevent Blindness with AdaptDx
An early AMD diagnosis leads to better outcomes. Imagine Dolores, a healthy 59-year-old female and your loyal patient for 20 years. During her annual exam, Dolores mentions having trouble seeing at night. You don’t see any signs of drusen but you don’t dismiss this symptom.
You ask Dolores to take the AdaptDx® test, and quickly discover that her results indicate subclinical age-related macular degeneration. Fortunately for Dolores, you caught this progressive disease at the earliest possible stage. Together, you can take steps to preserve her vision for years to come.
The Science Behind AdaptDx
Research conclusively shows that dark adaptation function is dramatically impaired from the earliest stages of AMD, with increasing deterioration as the disease progresses. Usually expressed as a night vision complaint, you can use impaired dark adaptation to identify patients with subclinical AMD up to three years before drusen are visible.
The AdaptDx®, created by MacuLogix®, makes dark adaptation testing affordable and accessible for any optometry or ophthalmology practice. The device automatically measures the number of minutes it takes for the eye to adapt from bright light to darkness—the Rod Intercept™ (RI).
With the AdaptDx test, you get a clear, objective measurement of retinal function with 90% sensitivity and 90% specificity for the presence of AMD. Diagnosing AMD early allows you to offer patients like Dolores a course of action to delay or prevent blindness from AMD.
Get a Free E-Book
Practical Guidelines for the Treatment of AMD
Comprehensive, evidence-based guidelines include the latest information on AMD classification, diagnosis, staging, and treatment.
Practicing with AdaptDx
These eye care professionals can’t imagine their practice without AdaptDx. Can you?
When I look at the future of managing macular degeneration, I see the AdaptDx as the essential tool in AMD management just as now I see the OCT as the essential tool in managing glaucoma in its earliest stages. By finding a disease early, and intervening appropriately we have the best chance of altering the course.
Optimize the AdaptDx workspace with accessories from MacuLogix